Immediate call for partner university and principal investigator for the further development of a UK Antimicrobial Registry (UKAR).

29th June 2020

BSAC is establishing a UK Drug Registry (UKAR) to provide prescribers and organisations the opportunity to capture real world usage of antimicrobial agents and identify where real clinical unmet needs lie. This will provide an invaluable resource for future research studies and also enable the sharing of best practice.

UKAR will be a collaborative epidemiological study through which BSAC partnerships with a UK university and industry partners. The Registry will initially be open for intravenous antibiotics, with a particular focus on multi-drug resistant organisms.

The registry will be overseen by an expert steering group to ensure appropriate consent and governance at all levels of implementation.

BSAC is now looking to engage a lead principal investigator to lead the study and also engage with a university partner who has experience of running other patient registries.
This will be a lean project with tight timescales but is an exciting opportunity to be part of a programme with national and international importance.

Please express interest to Tracey Guise, CEO,BSAC by July 10th 2020 by using the contact form available here.

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top